Molloy CA, Manning-Courtney P, Swayne S, et al. Lack of benefit of intravenous synthetic human secretin in the treatment of autism.
J Autism Dev Disord.
2002;32:545 - 551:2nd CD.
Unis AS, Munson JA, Rogers SJ, et al. A randomized, double-blind, placebo-controlled trial of porcine versus synthetic secretin for reducing symptoms of autism.
J Am Acad Child Adolesc Psychiatry.
2002;41:1315 - 1321.
Sponheim E, Oftedal G, Helverschou SB. Multiple doses of secretin in the treatment of autism: a controlled study.
Acta Paediatr.
2002;91:540 - 545.
Corbett B, Khan K, Czapansky-Beilman D, et al. A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism.
Clin Pediatr.
2001;40:327 - 331.
Roberts W, Weaver L, Brian J, et al. Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial.
Pediatrics.
2001;107:E71.
Coniglio SJ, Lewis JD, Lang C, et al. A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism.
J Pediatr.
2001;138:649 - 655.
Dunn-Geier J, Ho HH, Auersperg E, et al. Effect of secretin on children with autism: a randomized controlled trial.
Dev Med Child Neurol.
2000;42:796 - 802.
Owley T, Steele E, Corsello C, et al. A double-blind, placebo-controlled trial of secretin for the treatment of autistic disorder.
MedGenMed.
1999;6:E2.
Dolske MC, Spollen J, McKay S, et al. A preliminary trial of ascorbic acid as supplemental therapy for autism.
Prog Neuropsycholpharmacol Biol Psychiatry.
1993;17:765 - 774.
Rimland B, Callaway E, Dreyfus P. The effect of high doses of vitamin B
6
on autistic children: a double-blind crossover study.
Am J Psychiatry.
1978;135:472 - 475.
Nye C, Brice A. Combined vitamin B
6
-magnesium treatment in autism spectrum disorder (Cochrane Review).
Cochrane Database Syst Rev.
2002:CD003497.
Findling RL, Maxwell K, Scotese-Wojtila L, et al. High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutary effects in a double-blind, placebo-controlled study.
J Autism Dev Disord.
1997;27:467 - 478.
Tolbert L, Haigler T, Waits MM, et al. Brief report: lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium.
J Autism Dev Disord.
1993;23:193 - 199.
Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism.
N Engl J Med.
2002;347:1477 - 1482.
DeStefano F, Chen RT. Autism and measles-mumps-rubella vaccination: controversy laid to rest?
CNS Drugs.
2001;15:831 - 837.
Chez MG, Buchanan CP, Aimonovitch MC, et al. Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders.
J Child Neurol. 2002;17:833 - 837.
Field T, Lasko D, Mundy P, et al. Brief report: autistic children's attentiveness and responsivity improve after touch therapy.
J Autism Dev Disord. 1997;27:333 - 338.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.